Management of Post-Viral Rhinosinusitis with Fluticasone Nasal Spray

Introduction to Treatment

The European Position Paper on Rhinosinusitis (EPOS 2020) recommends fluticasone propionate nasal spray 200 mcg once daily for acute post-viral rhinosinusitis, as it significantly reduces total symptom scores compared to placebo in patients with symptoms lasting 5-10 days after a viral upper respiratory infection 1, 2
The effect size of fluticasone propionate nasal spray is small but statistically significant, with particular benefit for nasal congestion, sinus headache/pressure, and facial pain 1, 3

EPOS 2020 suggests prescribing nasal corticosteroids only when symptom reduction is considered necessary, not as routine treatment, because post-viral rhinosinusitis is self-limiting 4
Nasal congestion shows the most consistent improvement with fluticasone treatment in viral infections 2, 3

The evidence-based regimen for acute post-viral rhinosinusitis in adults and adolescents ≥12 years is fluticasone propionate 200 mcg once daily (2 sprays per nostril once daily) for 14-15 days 1, 2

Do not use fluticasone routinely for uncomplicated common colds without sinus involvement—the evidence supports use only when symptoms suggest post-viral rhinosinusitis (nasal congestion, facial pain/pressure, postnasal drip lasting >5-10 days) 1, 2
Fluticasone has not been shown to improve quality of life measures in post-viral rhinosinusitis, only symptom scores 4
The condition is self-limiting—most patients recover without treatment within 10-14 days 5, 6

Consider fluticasone nasal spray specifically for patients with a history of allergic rhinitis or chronic rhinitis who develop post-viral rhinosinusitis, as underlying inflammation may be exacerbated 5, 7
Patients with significant nasal congestion, facial pain/pressure, or postnasal drip persisting beyond 5-7 days after onset of viral symptoms may benefit from fluticasone 1, 2

Fluticasone is well-tolerated with minimal systemic effects at recommended doses 7
Common side effects include epistaxis (nosebleeds), pharyngitis, headache, and nasal irritation, occurring in <5% of patients 8

Antibiotics are not indicated for post-viral rhinosinusitis and show no benefit over placebo 1, 2
Oral corticosteroids are not recommended for post-viral rhinosinusitis due to lack of benefit at 7-14 days and potential harm 6
Antihistamines show no additive benefit when added to treatment for acute bacterial or post-viral rhinosinusitis 6

For patients presenting with viral upper respiratory infection symptoms, consider fluticasone 200 mcg once daily for 14 days if symptom relief is desired and symptoms have lasted 5-10 days with nasal congestion, facial pain/pressure, or postnasal drip 1, 2
If patient has history of allergies or chronic rhinitis, lower threshold to prescribe fluticasone, as these patients may have greater inflammatory burden 5, 7